{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:57:19Z","timestamp":1758473839564},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1053\/pcad.2003.2","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T21:00:41Z","timestamp":1047589241000},"page":"269-284","source":"Crossref","is-referenced-by-count":11,"title":["HIV infection and lipodystrophy"],"prefix":"10.1053","volume":"45","author":[{"given":"Donald P.","family":"Kotler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/pcad.2003.2_BIB1","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/00126334-200010001-00013","article-title":"Nutritional alterations associated with HIV infection","volume":"25","author":"Kotler","year":"2000","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/pcad.2003.2_BIB2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2003.2_BIB3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00002030-199813000-00012","article-title":"The effect of protease inhibitors on weight and body composition in HIV-infected patients","volume":"12","author":"Silva","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB4","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/pcad.2003.2_BIB6","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/00002030-200111090-00004","article-title":"Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways","volume":"15","author":"van der Valk","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB7","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(05)79053-X","article-title":"Severe premature coronary artery disease with protease inhibitors","volume":"351","author":"Henry","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/pcad.2003.2_BIB8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ajcn\/4.1.20","article-title":"The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease","volume":"4","author":"Vague","year":"1956","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/pcad.2003.2_BIB9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ajcn\/69.6.1162","article-title":"Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging","volume":"69","author":"Engelson","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/pcad.2003.2_BIB10","first-page":"107","article-title":"Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)","volume":"21","author":"Dong","year":"1991","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/pcad.2003.2_BIB11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","article-title":"\u2033Buffalo hump\u201d in men with HIV-1 infection","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/pcad.2003.2_BIB12","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB13","unstructured":"S Raghavan, AH Aidary, K Lester, et al., Gender differences in prevalence of body habitus changes and metabolic complications in HIV+ African American and Latino individuals from Harlem, Program of the 7th Conference on Retroviruses and Opportunistic Infections (abstr 27)."},{"key":"10.1053\/pcad.2003.2_BIB14","first-page":"589","article-title":"Interactions among sex, HIV infection, and fat redistribution","volume":"10","author":"Kotler","year":"2000","journal-title":"AIDS Read"},{"key":"10.1053\/pcad.2003.2_BIB15","unstructured":"N Muurahainen, G Santos, M Kleintop, et al., Gender differences in HIV-associated adipose redistribution syndrome (HARS): An update, Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections, January 30-February 2, 2000, San Francisco, CA (abstr 26)."},{"key":"10.1053\/pcad.2003.2_BIB16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00126334-200105010-00005","article-title":"Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ lymphocyte count and CD4+ lymphocyte percent age at baseline and use of protease inhibitors and stavudine","volume":"27","author":"Arpadi","year":"2001","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/pcad.2003.2_BIB17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/pcad.2003.2_BIB18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects","volume":"14","author":"Purnell","year":"2000","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(89)90225-8","article-title":"Hypertriglyceridemia in the acquired immunodeficiency syndrome","volume":"86","author":"Grunfeld","year":"1989","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2003.2_BIB20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9343(91)90536-7","article-title":"Circulating interferon alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome","volume":"90","author":"Grunfeld","year":"1991","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2003.2_BIB21","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1097\/00002030-200112070-00008","article-title":"Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile","volume":"15","author":"van der Valk","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB22","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB23","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","article-title":"Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled study","volume":"16","author":"Noor","year":"2002","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00002030-200204120-00005","article-title":"Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations","volume":"16","author":"Murata","year":"2002","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00126334-200107010-00005","article-title":"Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy","volume":"27","author":"Duong","year":"2001","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/pcad.2003.2_BIB26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/meta.2002.29999","article-title":"Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution","volume":"51","author":"Meininger","year":"2002","journal-title":"Metabolism"},{"key":"10.1053\/pcad.2003.2_BIB27","first-page":"E332","article-title":"Metabolic basis of HIV-lipodystrophy syndrome","volume":"283","author":"Sekhar","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1053\/pcad.2003.2_BIB28","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ajcn\/76.2.460","article-title":"Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men","volume":"76","author":"Meininger","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/pcad.2003.2_BIB29","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00002030-199912240-00002","article-title":"Fat distribution and metabolic changes in patients with HIV infection","volume":"13","author":"Safrin","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB30","unstructured":"C Grunfeld, Fat redistribution and metabolic abnormalities, Program and abstracts of the XIV International AIDS Conference, July 7-12, 2002, Barcelona, Spain (abstr TuOr158)."},{"key":"10.1053\/pcad.2003.2_BIB31","first-page":"295","article-title":"The environment and disease: Association or causation","volume":"58","author":"Bradford-Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1053\/pcad.2003.2_BIB32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB33","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/135965350100600301","article-title":"Antiretoviral therapy and the lipodystrophy syndrome, part 2: Concepts in aetiopathogenesis","volume":"6","author":"Nolan","year":"2001","journal-title":"Antiviral Ther"},{"key":"10.1053\/pcad.2003.2_BIB35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/341489","article-title":"Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy","volume":"35","author":"Dube","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1053\/pcad.2003.2_BIB36","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm1201-1327","article-title":"HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia","volume":"7","author":"Liang","year":"2001","journal-title":"Nat Med"},{"key":"10.1053\/pcad.2003.2_BIB37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00002030-200104130-00007","article-title":"Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy","volume":"15","author":"John","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB38","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/pcad.2003.2_BIB39","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00002030-200109280-00009","article-title":"Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy","volume":"15","author":"Shikuma","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB40","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V95.10.3191","article-title":"Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: Contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome","volume":"95","author":"Ledru","year":"2000","journal-title":"Blood"},{"key":"10.1053\/pcad.2003.2_BIB41","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","article-title":"Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy","volume":"25","author":"Mynarcik","year":"2000","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/pcad.2003.2_BIB42","unstructured":"JA Johnson, JB Albu, ES Engelson, et al., Studies of subcutaneous adipose tissue (SAT) in HIV+ subjects with and without lipodystrophy, Program and abstracts of the XIV International AIDS Conference, July 7-12, 2002, Barcelona, Spain (abstr ThPeB7357)."},{"key":"10.1053\/pcad.2003.2_BIB43","series-title":"Could anti-hepatitis C virus treatment with interferon and ribavirin enhance or endure lipoatrophy in patients previously treated with anti-HIV multitherapy?","author":"Bentata","year":"2001"},{"key":"10.1053\/pcad.2003.2_BIB44","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0140-6736(00)02717-3","article-title":"Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood","volume":"356","author":"Taskinen","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/pcad.2003.2_BIB45","first-page":"546","article-title":"Psychosocial impact of the lipodystrophy syndrome in HIV infection","volume":"10","author":"Collins","year":"2000","journal-title":"AIDS Read"},{"key":"10.1053\/pcad.2003.2_BIB46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00042560-200112150-00006","article-title":"Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection","volume":"28","author":"Ammassari","year":"2001","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/pcad.2003.2_BIB47","unstructured":"M Mary-Krause, L Cotte, M Partisani, et al., Impact of treatment with protease inhibitor (PI) on myocardial infarction (MI) occurrence in HIV-infected men, Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections, February 4-8, 2001, Chicago, IL (abstr 657)."},{"key":"10.1053\/pcad.2003.2_BIB48","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00126334-200208150-00002","article-title":"Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?","volume":"30","author":"Klein","year":"2002","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/pcad.2003.2_BIB49","first-page":"36","article-title":"Accelerated atherosclerosis in men infected with HIV","volume":"6","author":"Currier","year":"2001","journal-title":"Antiviral Ther"},{"key":"10.1053\/pcad.2003.2_BIB50","unstructured":"SA Bozzette, A Carpenter, U Bommakanty, et al., Cardio- and cerebrovascular outcomes with changing process of anti-HIV therapy in 36,776 US veterans, Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections, February 24-28, 2002, Seattle, WA (abstr LB9)."},{"key":"10.1053\/pcad.2003.2_BIB51","unstructured":"G Barbaro, G Di Lorenzo, G Gianaspro, et al., Incidence of coronary artery disease in HIV-infected patients or not protease inhibitors: A randomized, multicenter trial, Program and abstracts of the XIV International AIDS Conference, July 7-12, 2002, Barcelona, Spain (abstr WeOrB1307)."},{"key":"10.1053\/pcad.2003.2_BIB52","unstructured":"IJ Woolley, SP Johnsen, HT Sorensen, et al., Cardiovascular events in the MACS cohort and prior prophylaxis with macrolides for mycobacterium avium complex, Program and abstracts of the XIV International AIDS Conference, July 7-12, 2002, Barcelona, Spain (abstr ThPeB7282)."},{"key":"10.1053\/pcad.2003.2_BIB53","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1210\/jc.82.5.1332","article-title":"Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting","volume":"82","author":"Grinspoon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/pcad.2003.2_BIB54","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200109280-00010","article-title":"HIV protease inhibitor substitution in patients with lipodystrophy: A randomized, controlled, open-label, multicentre study","volume":"15","author":"Carr","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB55","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/bmj.288.6428.1401","article-title":"Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913","volume":"288","author":"Larsson","year":"1984","journal-title":"Br Med J"},{"key":"10.1053\/pcad.2003.2_BIB56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2796.1992.tb00595.x","article-title":"Evaluation of regional body fat distribution: Comparison between W\/H ratio and computed tomography in obese women","volume":"232","author":"Zamboni","year":"1992","journal-title":"J Intern Med"},{"key":"10.1053\/pcad.2003.2_BIB57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1079\/BJN19930104","article-title":"Abdominal diameters as indicators of visceral fat: Comparison between magnetic resonance imaging and anthropometry","volume":"70","author":"van der Kooy","year":"1993","journal-title":"Br J Nutr"},{"key":"10.1053\/pcad.2003.2_BIB58","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00042560-199903010-00003","article-title":"Studies of body composition and fat distribution in HIV-infected and control subjects","volume":"20","author":"Kotler","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/pcad.2003.2_BIB59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.1550-8528.1997.tb00557.x","article-title":"Sagittal diameter minus subcutaneous thickness. An easy-to-obtain parameter that improves visceral fat prediction","volume":"5","author":"Armellini","year":"1997","journal-title":"Obes Res"},{"key":"10.1053\/pcad.2003.2_BIB60","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ajcn\/75.3.587","article-title":"Use of the Durnin-Womersley formulae to estimate changes in subcutaneous fat content in HIV-infected subjects","volume":"75","author":"Andrade","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/pcad.2003.2_BIB61","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/j.1550-8528.1999.tb00404.x","article-title":"The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women","volume":"7","author":"Casey","year":"1999","journal-title":"Obes Res"},{"key":"10.1053\/pcad.2003.2_BIB62","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(00)02850-6","article-title":"Sonographic assessment of regional fat in HIV-1-infected people","volume":"356","author":"Martinez","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/pcad.2003.2_BIB63","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00002030-199905070-00009","article-title":"Reversion of metabolic abnormalities after switching from HIV protease inhibitors to nevirapine","volume":"13","author":"Martinez","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB64","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/00002030-199910220-00035","article-title":"The effects of discontinuing stavudine therapy on clinical and metabolic abnormalities in patients suffering from lipodystrophy","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB65","unstructured":"A Carr, D Smith, C Workman, et al., Switching stavudine or zidovudine to abacavir for HIV lipoatrophy: A randomised, controlled, open-label, multicentre, 24-week study, Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections, February 24-28, 2002, Seattle, WA (abstr 32)."},{"key":"10.1053\/pcad.2003.2_BIB66","unstructured":"M John, I James, E McKinnon, et al., A randomised, controlled, open-label study of revision of antiretroviral regimens containing stavudine (d4T) and\/or a protease inhibitor (PI) to zidovudine (ZDV)\/lamivudine (3TC)\/abacavir (ABC) to prevent or reverse lipoatrophy: 48-week data, Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections, February 24-28, 2002, Seattle, WA (abstr 700)."},{"key":"10.1053\/pcad.2003.2_BIB67","unstructured":"G McComsey, T Lonergan, R Fisher, et al., Improvements in lipoatrophy (LA) are observed after 24 weeks when stavudine (d4T) is replaced by either abacavir (ABC) or zidovudine (ZDV), Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections, February 24-28, 2002, Seattle, WA (abstr 701)."},{"key":"10.1053\/pcad.2003.2_BIB68","unstructured":"GJ Moyle, C Baldwin, BG Gazzard, A randomised open label study of 3 substitution strategies in hypercholesterolemic persons virologically controlled on first line antiretroviral therapy (ART), Program and abstracts of the XIV International AIDS Conference, July 7-12, 2002, Barcelona, Spain (abstr ThPeB7322)."},{"key":"10.1053\/pcad.2003.2_BIB69","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200108170-00007","article-title":"Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy","volume":"15","author":"Moyle","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB70","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s15010-001-2052-3","article-title":"Use of fibrates in the management of hyperlipidemia in HIV-infected patients receiving HAART","volume":"30","author":"Calza","year":"2002","journal-title":"Infection"},{"key":"10.1053\/pcad.2003.2_BIB71","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002030-200203080-00008","article-title":"Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047","volume":"16","author":"Fichtenbaum","year":"2002","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB72","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-73-6-1294","article-title":"Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects","volume":"73","author":"DeFronzo","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/pcad.2003.2_BIB73","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","article-title":"Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial","volume":"284","author":"Hadigan","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/pcad.2003.2_BIB74","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/jc.86.2.939","article-title":"Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance","volume":"86","author":"Hadigan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/pcad.2003.2_BIB75","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2337\/diacare.22.6.908","article-title":"Effect of troglitazone on body fat distribution in type 2 diabetic patients","volume":"22","author":"Mori","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1053\/pcad.2003.2_BIB76","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1572-0241.2000.01707.x","article-title":"Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States Food and Drug Administration","volume":"95","author":"Kohlroser","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/pcad.2003.2_BIB77","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/00002030-199907300-00015","article-title":"A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution","volume":"13","author":"Roubenoff","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB78","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1210\/jc.82.3.727","article-title":"Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure","volume":"82","author":"Johannsson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/pcad.2003.2_BIB79","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-199912030-00023","article-title":"Recombinant human growth hormone improves truncal adiposity and \u2018buffalo humps\u2019 in HIV-positive patients on HAART","volume":"13","author":"Torres","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB80","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1097\/00002030-199910220-00013","article-title":"Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV","volume":"13","author":"Wanke","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/pcad.2003.2_BIB81","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00042560-200208010-00002","article-title":"Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection","volume":"30","author":"Engelson","year":"2002","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062002001019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062002001019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T22:36:05Z","timestamp":1682462165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062002001019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S0033062002001019"],"URL":"https:\/\/doi.org\/10.1053\/pcad.2003.2","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}